During the past decade, CHU Bretonneau, Centre Henry Kaplan conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 5 clinical trials were completed, i.e. on average, 500% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "CHU Bretonneau, Centre Henry Kaplan" #1 collaborator was "Medivation, Inc." with 2 trials as a collaborator, "Breast International Group" with 1 trials as a collaborator and "Myriad Genetic Laboratories, Inc." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "CHU Bretonneau, Centre Henry Kaplan" are "Breast Cancer" (5 trials), "BRCA 1 Gene Mutation" (2 trials), "BRCA 2 Gene Mutation" (2 trials), "Breast Neoplasms" (2 trials) and "Estrogen Receptor Positive Tumor" (1 trials). Many other conditions were trialed in "CHU Bretonneau, Centre Henry Kaplan" in a lesser frequency.

Most popular intervention types in "CHU Bretonneau, Centre Henry Kaplan" are "Drug" (7 trials), "Procedure" (2 trials), "Other" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Trastuzumab" (2 trials), "talazoparib" (2 trials), "Bevacizumab" (1 trials), "Biopsy" (1 trials) and "Docetaxel" (1 trials). Other intervention names were less common.

The vast majority of trials in "CHU Bretonneau, Centre Henry Kaplan" are 4 trials for "Female" genders and 3 trials for "All" genders.

Currently, there are NaN active trials in "CHU Bretonneau, Centre Henry Kaplan". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in CHU Bretonneau, Centre Henry Kaplan, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in CHU Bretonneau, Centre Henry Kaplan, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".